Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Fractyl Health (NASDAQ:GUTS) presented prospective, randomized, double-blind, controlled six-month data from its REMAIN-1 ...

If you are researching HepatoBurn reviews in 2026, you are not alone. Interest in this supplement has surged quietly, not ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...